Udvalget for Humanmedicinske Lægemidler (CHMP) fandt, at Epoetin Alfa Hexal i overensstemmel - se med EU- kravene er påvist at have en kvalitet, sikkerhed og virkning, der svarer til Eprex/ Erypo.
The Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Epoetin Alfa Hexal has been shown to have a comparable quality, safety and efficacy profile to Eprex/ Erypo.